NCT02399943View on ClinicalTrials.gov

A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

March 31, 2022

Conditions
Colorectal CancerKRAS WildtypeNRAS WildtypeBRAF Wildtype
Interventions
DRUG

Trametinib

DRUG

Panitumumab

Trial Locations (1)

Unknown

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02399943 - A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter